Similar articles

• [Bioavailability evaluation of dermocorticoids using differential infrared thermography].

  Luong MS, Luong MP, Lok C, Carmi E, Chaby G, Viseux V. Luong MS, et al. Ann Dermatol Venereol. 2000 Aug-Sep;127(8-9):701-5. Ann Dermatol Venereol. 2000. PMID: 11011158 French.
• [The influence of vehicule composition and corticosteroids sensitivity on the vasoconstrictor activity of a new topical corticosteroid, difluprednate (author's transl)].

  Girard J, Sagon J, Barbier A, Tardieu JC, Lafille C. Girard J, et al. J Pharm Belg. 1978 Nov-Dec;33(6):341-50. J Pharm Belg. 1978. PMID: 748519 French. No abstract available.
• [Evaluation of topical corticosteroids. Effects on skin temperature and placebo effect (author's transl)].

  Durocher LP, Beilmann P. Durocher LP, et al. Dermatologica. 1975;151(3):168-76. Dermatologica. 1975. PMID: 1225654 French. No abstract available.
• Topical glucocorticosteroids.

  Fritz KA, Weston WL. Fritz KA, et al. Ann Allergy. 1983 Feb;50(2):68-76. Ann Allergy. 1983. PMID: 6337530 Review.
• [Topical corticosteroids].

  Duchesneau J, Grondin M. Duchesneau J, et al. Union Med Can. 1995 Mar;124(1):15-9. Union Med Can. 1995. PMID: 8540145 Review. French. No abstract available.